Trials / Sponsors / Kamari Pharma Ltd
Kamari Pharma Ltd
Network · 4 registered clinical trials — 1 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | Study of KM-023 in Healthy Volunteers and Patients With Olmsted Syndrome. Olmsted Syndrome | Phase 1 | 2025-07-08 |
| Completed | Assessment of KM-001 - Safety, Tolerability, and Efficacy in Patients With PPPK1 or PC Punctate Palmoplantar Keratoderma Type 1, Pachyonychia Congenita | Phase 1 | 2023-03-06 |
| Completed | Study Designed to Evaluate Safety and Efficacy of 1% Topical Formulation of KM-001 on Type 1 Punctate Palmopla Punctate Palmoplantar Keratoderma Type 1, Pachyonychia Congenita | Phase 1 | 2022-07-17 |
| Completed | KM-001 Cream for Treatment of Pruritus in Adult Patients With Lichen Simplex Chronicus (LSC) Lichen Simplex Chronicus | Phase 1 | 2022-05-24 |